Results for

Small Business Innovation Voucher Act of 2020 This bill requires the Small Business Administration to establish the Innovation Voucher Grant Program to aid small businesses in carrying out research, development, or commercialization of new or innovative products and services.

Small Business Innovation Voucher Act of 2019 This bill requires the Small Business Administration to establish the Innovation Voucher Grant Program to aid small businesses in carrying out research, development, or commercialization of new or innovative products and services.

American Critical Mineral Exploration and Innovation Act of 2020 This bill addresses the availability, development, and production of domestic critical minerals, including by providing incentives to increase domestic production of critical minerals that are needed to ensure the economic and national security of the United States.

Financial Services Innovation Act of 2019 This bill addresses the regulation of financial products and services. Specifically, the bill allows persons intending to offer a financial innovation to petition specified financial regulatory agencies regarding existing areas of regulation. A petitioner may request a modification or waiver of an agency regulation. The bill sets forth requirements regarding the petition process, a safe harbor for petitioners from enforcement, and enforceable compliance agreements. Agencies must biannually publish a list of financial regulatory areas the agency would consider modifying or waiving through the petition process. The bill also establishes Financial Services Innovation Offices at these agencies to assist petitioners. These offices must also generally support the development of financial innovations and coordinate with other offices to share data.

Research Advancing to Market Production for Innovators Act This bill provides commercialization services for federally funded small business research and development under the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Specifically, the bill (1) expedites the application and award process for SBIR proposals and STTR solicitations, (2) requires determinations of commercialization potential for projects undertaken through SBIR and STTR awards, (3) provides continued flexibility of technical and business assistance for SBIR and STTR awardees, (4) instructs participating federal agencies to designate a technology commercialization official to help awardees commercialize, and (5) requires the Small Business Administration and the U.S. Patent Office to reach an interagency agreement to help SBIR and STTR awardees with intellectual property protection.

Research Advancing to Market Production for Innovators Act This bill provides commercialization services for federally funded small business research and development under the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Specifically, the bill (1) expedites the application and award process for SBIR proposals and STTR solicitations, (2) requires determinations of commercialization potential for projects undertaken through SBIR and STTR awards, (3) provides continued flexibility of technical and business assistance for SBIR and STTR awardees, (4) instructs participating federal agencies to designate a technology commercialization official to help awardees commercialize, and (5) requires the Small Business Administration and the U.S. Patent Office to reach an interagency agreement to help SBIR and STTR awardees with intellectual property protection.

Innovation Network and Capital Act of 2019 This bill establishes and provides funds through FY2025 for a grant program in the National Institutes of Health (NIH) to expand the commercialization of biomedical products. NIH shall award grants or contracts to entities that have received funding from either the Small Business Innovation Research Program or the Small Business Technology Transfer Program of NIH. Awardees must use the funds to support participation in specified NIH programs and activities related to the commercialization stage of research, later stage research and development, technology transfer, and commercialization technical assistance.

Vehicle Innovation Act of 2019 This bill authorizes appropriations through FY2024 to the Department of Energy (DOE) for research, development, engineering, demonstration, and commercial application of innovative vehicle technologies. Among other things, the bill requires DOE to * conduct a program on materials, technologies, and processes with the potential to substantially reduce or eliminate petroleum use and the emissions of  U.S. passenger and commercial vehicles, including in the areas of natural gas and hydrogen vehicle technologies, electrification of vehicle systems, and hydraulic hybrid technologies; * implement a program of advanced vehicle manufacturing technologies and practices, including innovative processes to increase the production rate and decrease the cost of advanced battery and fuel cell manufacturing; and * seek opportunities to leverage resources and support initiatives of state and local governments in developing and promoting advanced vehicle technologies, manufacturing, and infrastructure.

Vehicle Innovation Act of 2019 This bill authorizes appropriations through FY2024 to the Department of Energy (DOE) for research, development, engineering, demonstration, and commercial application of innovative vehicle technologies. Among other things, the bill requires DOE to * conduct a program on materials, technologies, and processes with the potential to substantially reduce or eliminate petroleum use and the emissions of  U.S. passenger and commercial vehicles, including in the areas of natural gas and hydrogen vehicle technologies, electrification of vehicle systems, and hydraulic hybrid technologies; * implement a program of advanced vehicle manufacturing technologies and practices, including innovative processes to increase the production rate and decrease the cost of advanced battery and fuel cell manufacturing; and * seek opportunities to leverage resources and support initiatives of state and local governments in developing and promoting advanced vehicle technologies, manufacturing, and infrastructure.

Carbon Capture, Utilization, and Storage Innovation Act or theCCUS Innovation Act This bill addresses the capture, utilization, and storage of carbon dioxide. Among other things, the bill requires the Environmental Protection Agency to (1) establish a competitive prize program for certain technology projects that capture carbon dioxide directly from the air, (2) research and develop technologies or approaches that transform carbon dioxide generated by industrial processes into a product of commercial value, and (3) support research and infrastructure activities relating to carbon dioxide utilization by providing technical and financial assistance.

Regional Clean Energy Innovation Act This bill requires the Department of Energy to establish an Office of Advanced Clean Energy Technologies to manage a network of Regional Energy Innovation and Development Institutes (REIDIs) that accelerate clean energy innovation in the post-research stage. The termREIDIsmeans partnerships between governments, academic institutions, businesses, DOE national laboratories, and other clean energy entities that advance the development of early-stage innovations and support after proof concept to help clean energy innovations reach viability for commercial demonstration and deployment.

Accelerating Defense Innovation Act of 2019 This bill establishes a pilot program within the Department of Defense (DOD) to grant money to certain small businesses and modifies provisions related to DOD funding of small businesses through Small Business Administration programs. Specifically, the bill creates the Domestic Investment Pilot Program, which allows DOD and service acquisition executives for each military department to make a Small Business Innovation Research (SBIR) program award to small businesses that are majority-owned by multiple domestic venture investors. However, no more than 15% of DOD SBIR funds may be awarded to such small businesses. In addition, the bill doubles funding for the Defense Research and Development Rapid Innovation Program, which is a competitive, merit-based program designed to accelerate the deployment of technologies developed through SBIR projects. The bill also allows DOD to award Small Business Technology Transfer (STTR) program funds to accelerate the creation of small businesses and the commercialization of research innovations. Further, the bill authorizes discretionary technical and business assistance through the SBIR and STTR programs for the purpose of aiding small businesses with cybersecurity decision-making, problem-solving, and development and commercialization of new products and processes. Lastly, DOD, in consultation with the military departments, must establish at least three joint reserve detachments at locations of the Defense Innovation Unit to (1) support engagement and collaboration with commercial innovation hubs, and (2) accelerate the transition and adoption of commercial technologies for national security purposes.

PPE Innovation Act of 2020 This bill directs the Centers for Disease Control and Prevention (CDC) to carry out and expand programs for research and development of personal protective equipment, particularly with respect to equipment used by health care personnel. Generally, the bill requires the CDC to continue the activities of the National Personal Protective Technology Laboratory. This laboratory operates within the National Institute for Occupational Safety and Health and conducts scientific research, develops guidance, and disseminates information concerning workplace health hazards. The bill also specifically directs the CDC, in consultation with the Occupational Safety and Health Administration and the Food and Drug Administration, to establish a program in the laboratory to research personal protective equipment used in health care settings. In carrying out this program, the CDC must consult with health care personnel to inform research, conduct pilot tests of new equipment, and coordinate with manufacturers concerning the production of, and supply chain for, such equipment. Additionally, the Department of Health and Human Services shall enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to periodically conduct public workshops focused on research, development, and other issues concerning personal protective equipment.

Launching Energy Advancement and Development through Innovations for Natural Gas Act of 2019 This bill directs the Department of Energy (DOE) to establish a program for the capture of carbon dioxide produced during the generation of natural gas-generated power. Specifically, DOE must * identify opportunities to accelerate the development of commercially viable carbon capture technologies to reduce carbon dioxide emissions; * enter into cooperative agreements with certain entities to license, permit, construct, and operate at least three facilities to capture carbon dioxide from natural gas generating power facilities; and * identify any barriers to the commercial development of carbon capture technologies.

American Innovation and Manufacturing Leadership Act of 2020 This bill addresses the use and regulation of fluorinated compounds in products and manufacturing, including by requiring the Environmental Protection Agency to establish specified production and consumption baselines for the phase-down of specified fluorinated compounds.

Developing Innovation and Growing the Internet of Things Act or the DIGIT Act This bill requires the Department of Commerce to convene a working group of federal stakeholders to provide recommendations regarding the Internet of Things (IoT), and it establishes a steering committee composed of stakeholders outside the federal government to advise the working group. The IoT is a system of interrelated devices connected to a network and each other that exchange data without requiring human interaction (e.g., smart home devices, medical monitoring devices, and wearable fitness trackers). The working group must (1) identify federal laws and regulations, grant practices, budgetary or jurisdictional challenges, and other sector-specific policies that inhibit IoT development; (2) consider policies or programs that encourage and improve coordination among federal agencies with relevant responsibilities; (3) consider implementing recommendations from the steering committee; (4) examine how federal agencies can benefit from, use, prepare for, and secure the IoT; and (5) consult with nongovernmental stakeholders. The steering committee must advise the working group about laws, budgets, spectrum needs, individual privacy, security, small business challenges, and any international proceedings or negotiations affecting the IoT. Lastly, the Federal Communications Commission must (1) seek public comment on the IoT's spectrum needs, regulatory barriers, and growth with licensed and unlicensed spectrum; and (2) submit a summary of those comments to Congress.

Housing Innovation Act of 2019 This bill establishes the Office of Housing Innovation within the Department of Housing and Urban Development. The office must establish grant programs to support (1) planning efforts that address housing needs in urban areas; (2) research and studies to support, inform, and advise local governments on their plans for new housing and community development; and (3) outreach programs focused on issues related to housing, community development, and regional planning. The Government Accountability Office must report on the effectiveness of the grant programs.

American Innovation and Manufacturing Act of 2019 This bill addresses the use and regulation of fluorinated compounds in products and manufacturing, including by requiring the Environmental Protection Agency to establish specified production and consumption baselines for the phase-down of specified fluorinated compounds.

Innovators to Entrepreneurs Act of 2020 This bill expands eligibility for the Innovation Corps (I-Corps) program and requires development of an I-Corps course to support commercialization-ready participants. The bill requires the National Science Foundation (NSF) to allow grantees of the Small Business Innovation Research (SBIR) Program and other entities to participate in I-Corps courses. The cost of participation by such a grantee in a course may be furnished * through I-Corps Teams grants, * through funds awarded to grantees under the SBIR Program or the Small Business Technology Transfer (STTR) Program, * by the grantor federal agency using funds set aside for the SBIR and STTR Programs, or * by the participating teams. The NSF shall develop an I-Corps course, to be offered by I-Corps regional nodes, to support commercialization-ready participants. The course shall support participants that have completed an I-Corps course and participants that have made the decision to market an innovation. The Government Accountability Office shall report on the I-Corps Program, including by assessing the effects of the I-Corps on the commercialization of federally funded research and development, the higher education system, regional economies, and the national economy.

Innovators to Entrepreneurs Act of 2019 This bill expands eligibility for the Innovation Corps (I-Corps) program and requires development of an I-Corps course to support commercialization-ready participants. The bill requires the National Science Foundation (NSF) to allow grantees of the Small Business Innovation Research (SBIR) Program and other entities to participate in I-Corps courses. The cost of participation by such a grantee in a course may be furnished * through I-Corps Teams grants, * through funds awarded to grantees under the SBIR Program or the Small Business Technology Transfer (STTR) Program, * by the grantor federal agency using funds set aside for the SBIR and STTR Programs, or * by the participating teams. The NSF shall develop an I-Corps course, to be offered by I-Corps regional nodes, to support commercialization-ready participants. The course shall support participants that have completed an I-Corps course and participants that have made the decision to market an innovation. The Government Accountability Office shall report on the I-Corps Program, including by assessing the effects of the I-Corps on the commercialization of federally funded research and development, the higher education system, regional economies, and the national economy.

Innovators to Entrepreneurs Act of 2019 This bill expands eligibility for the Innovation Corps (I-Corps) program and requires development of an I-Corps course to support commercialization-ready participants. (Sec. 3) The bill requires the National Science Foundation (NSF) to allow grantees of the Small Business Innovation Research (SBIR) Program and other entities to participate in I-Corps courses. The cost of participation by such a grantee in a course may be furnished * through I-Corps Teams grants, * through funds awarded to grantees under the SBIR Program or the Small Business Technology Transfer (STTR) Program, * by the grantor federal agency using funds set aside for the SBIR and STTR Programs, or * by the participating teams. (Sec. 4) The NSF shall develop an I-Corps course, to be offered by I-Corps regional nodes, to support commercialization-ready participants. The course shall support participants that have completed an I-Corps course and participants that have made the decision to market an innovation. (Sec. 5) The Government Accountability Office shall report on the I-Corps Program, including by assessing the effects of the I-Corps on the commercialization of federally funded research and development, the higher education system, regional economies, and the national economy.

Launching Energy Advancement and Development through Innovations for Natural Gas Act of 2019 This bill directs the Department of Energy (DOE) to establish a program to award competitive grants to certain entities for the capture of carbon dioxide produced during the generation of natural gas-generated power. Specifically, DOE must * accelerate the development of commercially viable carbon capture technologies to reduce carbon dioxide emissions, including to improve the thermodynamics, kinetics, scalability, durability, and flexibility of carbon capture technologies used during the generation of electricity from natural gas power systems; * enter into cooperative agreements with certain entities to construct and operate no more than five facilities to capture carbon dioxide from natural gas generating power facilities; and * identify any barriers to the commercial development of carbon capture technologies.

Energy Innovation Corps This bill requires the Department of Energy (DOE) to carry out the Energy Innovation Corps Program. Under the program, DOE must help participants of the program develop skills and accelerate the commercial application of clean energy technologies and other technologies related to DOE's mission. Employees at DOE's national laboratories as well as researchers, students, and clean energy entrepreneurs may participate in the program.

Medical Innovation Act of 2020 This bill requires certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a relevant settlement agreement regarding specified violations must pay 0.75%-1.5% of its net income to the Department of Health and Human Services for each of its covered blockbuster drugs. A covered blockbuster drug is a drug that has at least $1 billion in net sales in a year and was developed, in whole or in part, through federal investments in medical research. Payments are divided between the FDA and the NIH in proportion to the discretionary funding of those agencies, excluding FDA user fees. Payments are not disbursed if appropriations for the FDA or the NIH are lower than in the prior fiscal year. Priorities for payments must include advancing regulatory science for medical products and research related to diseases that disproportionately account for federal health care spending. A covered blockbuster drug for which a manufacturer has not made a required payment is considered misbranded and subject to prohibitions on introducing or receiving misbranded drugs in interstate commerce.

Medical Innovation Act of 2019 This bill requires certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a relevant settlement agreement regarding specified violations must pay 0.75%-1.5% of its net income to the Department of Health and Human Services for each of its covered blockbuster drugs. A covered blockbuster drug is a drug that has at least $1 billion in net sales in a year and was developed, in whole or in part, through federal investments in medical research. Payments are divided between the FDA and the NIH in proportion to the discretionary funding of those agencies, excluding FDA user fees. Payments are not disbursed if appropriations for the FDA or the NIH are lower than in the prior fiscal year. Priorities for payments must include advancing regulatory science for medical products and research related to diseases that disproportionately account for federal health care spending. A covered blockbuster drug for which a manufacturer has not made a required payment is considered misbranded and subject to prohibitions on introducing or receiving misbranded drugs in interstate commerce.